Goodwin partner Willy Jay successfully argues for Teva Pharmaceutical in Teva v. Sandoz.
Documents and analysis to help public companies prepare for the year-end reporting and the upcoming annual meeting season.
Goodwin attorneys advise on Foundation Medicine-Roche tender offer and strategic collaboration.
Goodwin Procter’s litigation attorneys have delivered key victories on a wide range of complex legal matters for clients.
Guidebook examines regulatory and intellectual property issues for biologic drug products.
VIDEO: Deborah Birnbach Discusses Recent SEC Enforcement of Section 16 Filing Obligations
VIDEO: Sarah Concannon Discusses Insider Trading on Directors Letter
VIDEO: Gus Coldebella Discusses Keeping Your Data Safe Online
VIDEO: Carl Metzger Discusses Social Media and Crisis Management
Goodwin Procter Advises Deutsche Asset & Wealth Management on £327M Sale of Tower Place in London
PRESS: Litigator of the Week: William Jay of Goodwin Procter (The AmLaw Litigation Daily)
Goodwin Advises Thoma Bravo in Sale of Telestream to Genstar Capital
Goodwin Prevails for Teva Pharmaceutical in U.S. Supreme Court Victory
Goodwin Procter Offers Public Interest Fellowships to Law Students of Color for 10th Consecutive Year
Goodwin Advises on FinTech Deals Totaling $2B in 2014; Ranks Among Most Active Law Firms
IP Advisor: The Year Ahead in Patent Law and More
Supreme Court Clarifies Timing of Appeals in MDL Cases
Supreme Court Orders Claim Construction Deference in Seminal Patent Case Argued by Goodwin Procter